Ekonomisk modellering inom diabetes och fetma


IHE has considerable experience in cutting edge research on the economics of obesity and diabetes, including more than 50 peer-reviewed publications.

IHE works with health authorities, life science companies, and academia on projects ranging from developing national treatment guidelines to estimating future disease burden and from early stage decision-making to market access.

IHE staff:

      • Have developed two internationally established and validated economic models of Type 2 diabetes, which have been accepted by HTA authorities in Sweden, Norway, U.K., Canada, Scotland, Ireland, and Australia
      • Have developed an economic micro-simulation model of Type 1 diabetes, which has been used for the Swedish Dental and Pharmaceutical Benefits Agency (TLV) for decision-making, among others
      • Have collaborated successfully with life science companies to obtain market access in European and North American countries
      • Have been commissioned by the National Board of Health and Welfare in Sweden to assist with development of diabetes treatment guidelines
      • Supervise doctoral students at Lund University and Karolinska Institute, perform peer review, and participate in diabetes-related advisory boards as health economics experts
      • Serve on the executive committee of biennial Mt. Hood Diabetes Modelling Challenge Network

Special areas of competence include

      • Economic modelling and market access support
      • Model development
      • Analysis of registry data and real-world evidence
      • Literature review
      • Patient preferences and Willingness-to-Pay

To Publications

IHE and Economic Modelling of Diabetes

Read more about IHE’s health economics simulation models in the area of diabetes


For more information, please contact: diabetesmodelling@ihe.se